Alphagalileo > Item Display

St. Jude Children’s Research Hospital phase II clinical trial results suggest that the monoclonal antibody hu14.18K322A could help change treatment of....

Related Keywords

University Of Southern California ,California ,United States ,Taiwan ,San Diego ,Memorial Hospital ,Elizabeth Stewart ,Jacquelyn Hank ,Andrew Davidoff ,Michael Bishop ,Wayne Furman ,Sara Federico ,Los Angeles ,Chia Wei Hsu ,Rachel Brennan ,Alice Yu ,Matthew Krasin ,Paul Sondel ,Linkou Chang Gung ,Beth Mccarville ,Alberto Pappo ,Stephen Gillies ,Brandon Triplett ,Barry Shulkin ,Victor Santana ,Sara Helmig ,Haitao Pan ,Jianrong Wu ,University Of California ,Drug Administration ,Cure Childhood Cancer Foundation ,University Of Hong Kong ,Jude Children Research Hospitalclinical ,University Of Wisconsin ,Institute Of Stem Cell ,Chang Gung University ,Merck Kga ,Translational Cancer Research ,Merck Kgaa ,Serono ,University Of Kentucky ,Department Of Oncology ,Jude Children ,Research Hospitalclinical ,German Based Merck ,Teresa Santiago ,Fariba Navid ,Hospital Los Angeles ,Southern California ,Stem Cell ,Linkou Chang Gung Memorial Hospital ,Wing Leung ,Kid Cancer ,